Business · Earlier selection
Bristol blood-test venture launches with £705,000 backing
Dimension Biotechnologies has launched to develop a blood test aimed at identifying damage to small blood vessels.
The University of Bristol says its spinout has secured £490,000 in investment and £215,000 in grant funding. The test remains a development project; the announcement is not evidence of an available or clinically validated diagnostic service.
GO TO THE SOURCE
University of Bristol ↗ (opens a new tab)Primary institutional report or research paper, independently condensed. Findings and proposals are attributed to the source, with their limitations; no source prose, charts or photography reproduced.
AI-assisted original summary, checked against the linked source on 20 Sept 2026, 01:17 BST. Illustration is AI generated and does not document the event.
Report an error or rights concern